Citation:Kakehi Y, Kamoto T, Shiraishi T, Ogawa O, Suzukamo Y, Fukuhara S, et al 2008

From Cancer Guidelines Wiki

Citation


Kakehi Y, Kamoto T, Shiraishi T, Ogawa O, Suzukamo Y, Fukuhara S, et al. Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer. Jpn J Clin Oncol 2008 Feb;38(2):122-8 Available from: http://www.ncbi.nlm.nih.gov/pubmed/18272471.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Kakehi Y, Kamoto T, Shiraishi T, Ogawa O, Suzukamo Y, Fukuhara S, et al 2008For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?Katherine Sheridancompleted
Kakehi Y, Kamoto T, Shiraishi T, Ogawa O, Suzukamo Y, Fukuhara S, et al 2008 2For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?Dr Albert Chetcuti BTech(Biotech) Hons, PhDcompleted
Kakehi Y, Kamoto T, Shiraishi T, Ogawa O, Suzukamo Y, Fukuhara S, et al 2008 3For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?Dr. med. univ. Dana Stefanoviccompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Active surveillance
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Kakehi_Y,_Kamoto_T,_Shiraishi_T,_Ogawa_O,_Suzukamo_Y,_Fukuhara_S,_et_al_2008&oldid=70590"